US Stock Insider Trading | GeneDx Holdings disclosed details of six insider transactions on March 5

K-LinePoet · 2026-04-07T20:45:03+00:00

March 5, 2026, GeneDx Holdings disclosed multiple insider transactions, including a stock sale record by Director Stueland Katherine on March 4, 2026, with a significant total amount. GeneDx is committed to improving healthcare through data analytics and health intelligence platforms.

K-LinePoet

2026-04-07 20:45:03

Abstract generation in progress

March 5, 2026, GeneDx Holdings (WGS) disclosed six insider transactions by company insiders. Director Stueland Katherine sold 10.5k shares on March 4, 2026.

[Recent Insider Transactions]

Disclosure date	Position	Name	Transaction date	Buy/Sell	Quantity	Price per share/USD	Total amount/USD
March 5, 2026	Director	Stueland Katherine	March 4, 2026	Sold	10.5k	78.61	822.6k
March 5, 2026	Director	Stueland Katherine	March 4, 2026	Sold	5861	77.63	455k
March 5, 2026	Executive	Feeley Kevin	March 4, 2026	Sold	1424	77.63	110.5k
March 5, 2026	Director	Stueland Katherine	March 4, 2026	Sold	9133	79.25	723.8k
March 5, 2026	Executive	Feeley Kevin	March 4, 2026	Sold	2543	78.61	199.9k
March 5, 2026	Executive	Feeley Kevin	March 4, 2026	Sold	2220	79.25	175.9k
March 3, 2026	Executive	Feeley Kevin	March 2, 2026	Sold	287	77.52	22.2k
February 6, 2026	Executive	Dechairo Bryan	February 4, 2026	Sold	100	90.45	9,045.40
February 6, 2026	Executive	Dechairo Bryan	February 4, 2026	Sold	779	83.04	647,000
February 6, 2026	Executive	Dechairo Bryan	February 4, 2026	Sold	100	91.92	9,192.00

[Company Profile]

GeneDx Holdings Corp. is a company incorporated in Delaware on July 10, 2020. Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 builds dynamic models of human health and defines optimal personalized health trajectories by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data, thereby transforming healthcare. Centrellis is their innovative health intelligence platform, capable of gaining a more comprehensive understanding of diseases and health and providing science-driven solutions for the most urgent medical needs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes